Stern, Ute M.
Wagenpfeil, Gudrun
Weber, Susanne N.
Alqahtani, Saleh A.
Michel, Maurice
Schattenberg, Jörn M. https://orcid.org/0000-0002-4224-4703
Funding for this research was provided by:
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Article History
Received: 16 September 2025
Accepted: 20 December 2025
First Online: 14 February 2026
Declarations
:
: MM declares consultant honorary from Atheneum, Boehringer Ingelheim, Ipsen; speaker honorarium from AbbVie, Astra Zeneca, Cogitando, Coliquio, Daiichi Sankyo, Gilead Sciences, GSK, Ipsen, Novo Nordisk, StreamedUp. JMS declares consultant honorary from Akero, Alentis, Alexion, Altimmune, Astra Zeneca, 89Bio, Boehringer Ingelheim, Boston Pharmaceuticals, Gilead Sciences, GSK, Ipsen, Inventiva Pharma, Madrigal Pharmaceuticals, Kríya Therapeutics, Eli Lilly, eTherapeutics, Merck, MSD Sharp & Dohme GmbH, Novo Nordisk, Roche; speaker honorarium from AbbVie, Boehringer Ingelheim, Gilead Sciences, Ipsen, Lilly, Madrigal Pharmaceuticals, MSD, Novo Nordisk. Stockholder options: Hepta Bio.